0001136174FALSE00011361742022-02-082022-02-080001136174us-gaap:CommonStockMember2022-02-082022-02-080001136174us-gaap:SeriesAPreferredStockMember2022-02-082022-02-08

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  February 8, 2022

Ontrak, Inc.
(Exact name of registrant as specified in its charter)
Delaware 001-31932 88-0464853
(State or other jurisdiction
of incorporation)
(Commission File Number) (IRS Employer
Identification No.)

2120 Colorado Ave., Suite 230, Santa Monica, CA 90404
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code   (310) 444-4300


(Former name or former address, if changed since last report.)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.0001 par value OTRK The NASDAQ Global Market
9.50% Series A Cumulative Perpetual Preferred Stock, $0.0001 par value OTRKP The NASDAQ Global Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  






Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 10, 2022, Ontrak, Inc. (the “Company”) accepted Mr. Gus Giraldo’s resignation from the Company’s Board of Directors and all of its committees effective February 11, 2022. Mr. Giraldo has accepted a position at CVS Health, Head of Markets – Healthcare Benefits and his resignation from the Company’s Board was made to avoid any conflict of interest that could arise because of his new position with the health plan. Mr. Giraldo’s resignation was not due to any disagreement on any matter relating to the Company’s operations, policies, or practices.

On February 8, 2022, the Company also accepted Mr. Robert Newton’s resignation effective immediately from his roles as General Counsel and Secretary of the Company. Mr. Newton has resigned for personal family medical and health reasons and his resignation was not due to any disagreement on any matter relating to the Company’s operations, policies, or practices. Mr. Newton will continue to render services to the Company for a limited period to be mutually agreed with the Company related to certain contractual and other specific pending matters.
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Ontrak, Inc.
Date:  February 11, 2022 By: /s/ Brandon H. LaVerne
Brandon H. LaVerne
Chief Financial Officer

1